Horseradish Peroxidase-Catalyzed Oxidation of Rifampicin: Reaction Rate Enhancement by Co-oxidation with Anti-inflammatory Drugs
-
- Santos Fernanda de Jesus Notário dos
- Department of Clinical Analysis, Faculty of Pharmaceutical Sciences, UNESP - São Paulo State University
-
- Ximenes Valdecir Farias
- Department of Clinical Analysis, Faculty of Pharmaceutical Sciences, UNESP - São Paulo State University
-
- Fonseca Luiz Marcos da
- Department of Clinical Analysis, Faculty of Pharmaceutical Sciences, UNESP - São Paulo State University
-
- Faria Oliveira Olga Maria Mascarenhas de
- Department of Biochemistry and Chemistry Technology, Institute of Chemistry, UNESP - São Paulo State University
-
- Brunetti Iguatemy Lourenço
- Department of Clinical Analysis, Faculty of Pharmaceutical Sciences, UNESP - São Paulo State University
Search this article
Description
The tuberculostatic drug rifampicin has been described as a scavenger of reactive species. Additionally, the recent demonstration that oral therapy with a complex of rifampicin and horseradish peroxidase (HRP) was more effective than rifampicin alone, in an animal model of experimental leprosy, suggested the importance of redox reactions involving rifampicin and their relevance to the mechanism of action. Hence, we studied the oxidation of rifampicin catalyzed by HRP, since this enzyme may represent the prototype of peroxidation-mediated reactions. We found that the antibiotic is efficiently oxidized and that rifampicin-quinone is the product, in a reaction dependent on both HRP and hydrogen peroxide. The steady-state kinetic constants Kmapp (101±23 μmol/l), Vmaxapp (0.78±0.09 μmol/l·s−1) and kcat (5.1±0.6 s−1) were measured (n=4). The reaction rate was increased by the addition of co-substrates such as tetramethylbenzidine, salicylic acid, 5-aminosalicylic acid and paracetamol. This effect was explained by invoking an electron-transfer mechanism by which these drugs acted as mediators of rifampicin oxidation. We suggested that this drug interaction might be important at the inflammatory site.
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 28 (10), 1822-1826, 2005
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204626832512
-
- NII Article ID
- 130000113574
- 110003666347
-
- NII Book ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 7452833
-
- PubMed
- 16204929
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed